The molecular histology of neoplasia: The role of the cadherin/catenin complex

Histopathology

Volumn 31, Issue 2, 1997, Pages 107-111

  Smith, M E F ^a   Pignatelli, M ^b  

^a DERRIFORD HOSPITAL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Cadherin; Carcinoma; Catenin; Epithelioid

Indexed keywords

ACTIN; ALPHA CATENIN; AMINO ACID; BETA CATENIN; CADHERIN; CALCIUM; CATENIN; COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR; INTESTINAL TREFOIL FACTOR; NERVE CELL ADHESION MOLECULE; PROTEIN; SCATTER FACTOR; UVOMORULIN; VANADIC ACID;

CARCINOGENESIS; CELL ADHESION; COLON POLYPOSIS; EPITHELIOID CELL; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; IMMUNOHISTOCHEMISTRY; MELANOCYTE; NEOPLASM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SCHWANN CELL;

LOTUS;

EID: 0030847109     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1997.2350845.x     Document Type: Review

References (65)

1. Edelman GM, Crossin KL. Cell adhesion molecules: implications for a molecular histology. Ann. Rev. Biochem. 1991; 60; 155-190.
2. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991; 251; 1451-1455.
3. Nose A, Nagafuchi A, Takeichi M. Expressed recombinant cadherins mediate cell sorting in model systems. Cell 1988; 54; 993-1001.
4. Matsuzaki F, Mege R-M, Jaffe SH et al. cDNAs of cell adhesion molecules of different specificity induce changes in cell shape and border formation in cultured S180 cells. J. Cell Biol. 1990; 110; 1239-1252.
5. Shapiro L, Fannon AM, Kwong PD et al. Structural basis of cell-cell adhesion by cadherins. Nature 1995; 374; 327-336.
6. Lewis JE, Jensen PJ, Johnson KR, Wheelock MJ. E-cadherin mediates adherens junction organization through protein kinase C. J. Cell. Sci. 1995; 108; 3615-3621.
7. Ozawa M, Ringwald M, Kemler R. Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. Proc. Natl. Acad. Sci. USA 1990; 87; 4246-4250.
8. Ozawa M, Kemler R. Molecular organization of the uvomorulin-catenin complex. J. Cell Biol. 1992; 116; 989-996.
9. McPherson JD, Morton RA, Ewing CM et al. Assignment of the human alpha-catenin gene (CTNNA1) to chromosome 5q21-q22. Genomics 1994; 19; 188-190.
10. Krauss C, Liehr T, Hulsken J et al. Localization of the human beta-catenin gene (CTNNB1) to 3p21: a region implicated in tumor development. Genomics 1994; 23; 272-274.
11. Aberle H, Montagna M, Lynch HT et al. The human plakoglobin gene localizes on chromosome 17q21 and is subjected to loss of heterozygosity in breast and ovarian cancers. Proc. Natl. Acad. Sci. USA 1995; 92; 6384-6388.
12. Jou TS, Stewart DB, Stappert J, Nelson WJ, Marrs JA. Genetic and biochemical dissection of protein linkages in the cadherin-catenin complex. Proc. Natl. Acad. Sci. USA 1995; 92; 5067-5071.
13. Nathke IS, Hinck L, Swedlow JR, Papkoff J, Nelson WJ. Defining interactions and distributions of cadherin and catenin complexes in polarized epithelial cells. J. Cell Biol. 1994; 125; 1341-1352.
14. Hinck L, Nathke IS, Papkoff J, Nelson WJ. Dynamics of cadherin/catenin complex formation: novel protein interactions and pathways of complex assembly. J. Cell Biol. 1994; 125; 1327-1340.
15. Su LK, Vogelstein B, Kinzler KW. Association of the APC tumor suppressor protein with catenins. Science 1993; 262; 1734-1737.
16. Rubinfeld B, Souza B, Albert I et al. Association of the APC gene product with beta-catenin. Science 1993; 262; 1731-1734.
17. Powell SM, Zilz N, Beazer-Barclay Y et al. APC mutations occur early during colorectal tumorigenesis. Nature 1992; 359; 235-237.
18. Bodmer W, Bishop T, Karran P. Genetic steps in colorectal cancer [news]. Nat. Genet. 1994; 6; 217-219.
19. Goyette MC, Cho K, Fasching CL et al. Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol. Cell Biol. 1992; 12; 1387-1395.
20. Smith KJ, Levy DB, Maupin P, Pollard TD, Vogelstein B, Kinzler KW. Wild-type but not mutant APC associates with the microtubule cytoskeleton. Cancer Res. 1994; 54; 3672-3675.
21. Pignatelli M, Bodmer WF. Genetics and biochemistry of collagen binding triggered glandular differentiation in a human colon carcinoma cell line. Proc. Natl. Acad. Sci. USA 1988; 85; 5561-5565.
22. Liu D, Nigam AK, Lalani KN, Stamp GWH, Pignatelli M. Transfection of E-cadherin into a human colon carcinoma cell line induces differentiation and inhibits growth in vitro. Gut 1993; 34; 627 (abstract).
23. Smith KJ, Johnson KA, Bryan TM et al. The APC gene product in normal and tumor cells. Proc. Natl. Acad. Sci. USA 1993; 90; 2846-2850.
24. Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr. Opin. Cell Biol. 1993; 5: 806-811.
25. Marcel M, Bracke M, Van Roy F. Invasion promoter versus invasion suppressor molecules: the paradigm of E-cadherin. Mol. Biol. Rep. 1994; 19; 45-67.
26. Behrens J, Mareel MM, Van Roy FM, Birchmeier W. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J. Cell Biol. 1989; 108; 2435-2447.
27. Frixen UH, Behrens J, Sachs M et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol. 1991; 113; 173-185.
28. Vleminckx K, Vakaet L, Mareel M, Fiers W, Van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991; 66; 107-119.
29. Rasbridge SA, Gillett CE, Sampson SA, Walsh FS, Millis RR. Epithelial (E-) and placental (P-) cadherin cell adhesion molecule in breast carcinoma. J. Pathol. 1993; 169; 245-250.
30. Matsuura K, Kawanishi J, Fujii S et al. Altered expression of E-cadherin in gastric cancer tissues and carcinomatous fluid. Br. J. Cancer 1992; 66; 1122-1130.
31. Becker K-F, Atkinson MJ, Reich U et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res. 1994; 54; 3845-3852.
32. Dorudi S, Sheffield JP, Poulsom R, Northover JMA, Hart IR. E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Am. J. Pathol. 1993; 142; 981-986.
33. Gagliardi G, Kandemir O, Liu D et al. Changes in E-cadherin immunoreactivity in the adenoma-carcinoma sequence of the large bowel. Virchows Archiv. 1995; 426; 149-154.
34. Umbas R, Isaacs WB, Bringuier PP et al. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res. 1994; 54; 3929-3933.
35. Moll R, Mitze M, Frixen UH, Birchmeier W. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am. J. Pathol. 1993; 143; 1731-1742.
36. Siitonen SM, Kononen JT, Helin HJ, Rantala IS, Holli KA, Isola JJ. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am. J. Clin. Pathol. 1996; 105; 394-402.
37. Bringuier PP, Umbas R, Schaafsma HE, Karthaus HFM, Debruyne FMJ, Schalken JA. Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res. 1993; 53; 3241-3245.
38. Syrigos KN, Krausz T, Waxman J et al. E-cadherin expression in bladder cancer using formalin-lixed paraffin-embedded tissues: correlation with histopathological grade, tumour stage and survival. Int. J. Cancer 1995; 64; 367-370.
39. Pignatelli M, Ansari TW, Gunter P et al. Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage. J. Pathol. 1994; 174; 243-248.
40. Jankowski JA, Newham PM, Kandemir O, Hirano S, Takeichi M, Pignatelli M. Differential expression of E-cadherin in normal, metaplastic and dysplastic oesophageal mucosa: a putative biomarker. Int. J. Oncol. 1994; 4; 441-448.
41. Jawhari A, Jordan S, Poole S, Browne P, Pignatelli M, Farthing M. Expression of the E-cadherin-catenin complex in gastric carcinoma: correlation with pathological characteristics and survival. Gastroenterology 1997; 112; 46-54.
42. Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K, Birchmeier W. E-cadherin in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res. 1991; 51; 6328-6337.
43. Vessey CJ, Wilding J, Folarin N et al. Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma. J. Pathol. 1995; 176; 151-159.
44. Watabe M, Nagafuchi A, Tsukita S, Takeichi M. Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line. J. Cell Biol. 1994; 127; 247-256.
45. Cowley GP, Smith MEF. Modulation of E-cadherin expression and morphological phenotype in the intravascular component of adenocarcinomas. Int. J. Cancer 1995; 60; 325-329.
46. Marcel MM, Behrens J, Birchmeier W et al. Down-regulation of E-cadherin expression in Madin Darby Canine Kidney (MDCK) cells inside tumors of nude mice. Int. J. Cancer 1991; 47; 922-928.
47. Lee SW. H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nature Med. 1996; 2; 776-782.
48. Morton RA, Ewing CM, Nagafuchi A, Tsukita S, Isaacs WB. Reduction of E-cadherin levels and deletion of the α-catenin gene in human prostate cancer cells. Cancer Res. 1993; 53; 3585-3590.
49. Kadowaki T, Shiozaki H, Inoue M et al. E-cadherin and α-catenin expression in human esophageal cancer. Cancer Res. 1994; 54; 291-296.
50. Shiozaki H, Iihara K, Oka H et al. Immunohistochemical detection of α-catenin expression in human cancers. Am. J. Pathol. 1994; 144; 667-674.
51. Ochiai A, Akimoto S, Shimoyama Y, Nagafuchi A, Tsukita S, Hirohashi S. Frequent loss of α-catenin expression in scirrhous carcinomas with scattered cell growth. Jpn J. Cancer Res. 1994; 85; 266-273.
52. Hashizume R, Koizumi H, Ihara A, Ohta T, Uchikoshi T. Expression of β-catenin in normal breast tissue and breast carcinoma: a comparative study with epithelial cadherin and α-catenin. Histopathology 1996; 29; 139-146.
53. Takayama T, Shiozaki H, Shibamoto S et al. β-catenin expression in human cancers. Am. J. Pathol. 1996; 148; 39-46.
54. Pignatelli M, Vessey CJ. Adhesion molecules: novel molecular tools in tumor pathology. Hum. Pathol. 1994; 25; 849-856.
55. Matsuyoshi N, Hamaguchi M, Taniguchi S, Nagafuchi A, Tsukita S, Takeichi M. Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts. J. Cell Biol. 1992; 118; 703-714.
56. Behrens J, Vakaet L, Friis R et al. Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/β-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J. Cell Biol. 1993; 120; 757-766.
57. Shibamoto S, Hayakawa K, Takeuchi T et al. Tyrosine phosphorylation of β-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells. Cell Adhesion Comm. 1994; 1; 295-305.
58. Pignatelli M. Mechanisms of cell adhesion during epithelial restitution in the gastrointestinal tract. Yale J. Biol. Med. 1997; 69; 131-135.
59. Hatta K, Nose A, Nagafuchi A, Takeichi M. Cloning and expression of cDNA encoding a neural calcium-dependent cell adhesion molecule: its identity in the cadherin gene family. J. Cell Biol. 1988; 106; 873-881.
60. Mege R-M, Matsuzaki F, Gallin WJ, Goldberg JI, Cunningham BA, Edelman GM. Construction of epithelioid sheets by transfection of mouse sarcoma cells with cDNAs for chicken cell adhesion molecules. Proc. Natl. Acad. Sci. USA 1988; 85; 7274-7278.
61. Ashton-Key M, Cowley GP, Smith MEF. Cadherins in reactive lymph nodes and lymphomas: high expression in anaplastic large cell lymphomas. Histopathology 1996; 28; 55-59.
62. Smith MEF, Cowley GP, Dogan A, Weiss SW, Fisher C. E-cadherin is a differentiation antigen of normal Schwann cells and is expressed in epithelioid Schwann cell tumours. J. Pathol. 1994; 173; 181A.
63. Tang A, Eller MS, Hara M, Yaar M, Hirohashi S, Gilchrest BA. E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro. J. Cell Sci. 1994; 107; 983-992.
64. Mooi WJ, Krausz T. Common acquired melanocytic naevi. In Mooi WJ, Krausz T eds. Biopsy Pathology of Melanocytic Disorders. 1st ed. London: Chapman & Hall, 1992; 56-105.
65. Cowley GP, Smith MEF. Cadherin expression in melanocytic naevi and malignant melanomas. J. Pathol. 1996; 179; 183-187.